drugset / Trial / NCT02024204

Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program

NCT02024204

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to understand why patients in the World Trade Center program have continuing breathing problems. This study will improve investigators understanding of breathing problems among individuals with World Trade Center exposure by allowing them to review and monitor medication use, lung function, and examine other conditions that can contribute to problems with breathing. The findings from the study will help investigators understand why some people have persistent lower respiratory symptoms (breathing problems) after their exposure to World Trade Center dust and fumes, and may help guide better management and treatment of these symptoms.

Timeline

Start
2014-04-09
Primary completion
2017-05-17
Completion
2017-05-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone propionate Other / unclassified 230 ug Inhaled
Comparator Salmeterol Other / unclassified 21 ug Inhaled

Indications